Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients

Conditions:   Salivary Gland Cancer;   Salivary Duct Carcinoma;   Adenoid Cystic Carcinoma Intervention:   Drug: Lutetium-177-PSMA-I&T Sponsors:   Radboud University;   Dutch Cancer Society Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials